Skip to main content

Ibsrela (Tenapanor) & Inflammatory Bowel Disease (IBD)

    Basic Details
    Status
    Ongoing
    Last Updated
    Monday, September 16, 2019
    Health Outcome(s)
    inflammatory bowel disease (IBD)
    Purpose
    Drug and Outcome Analysis
    Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR
    Yes